台股 » 個股 » 和康生 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

和康生

(1783)
可現股當沖
  • 股價
    43.35
  • 漲跌
    ▼0.05
  • 漲幅
    -0.12%
  • 成交量
    49
  • 產業
    上市 生技醫療類股
  • 127人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
和康生 (1783)籌碼相關-群益金鼎-館前 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/034042.54547.55052.55557.5May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

群益金鼎-館前 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/02043.5500.0043.3503220.00%
2025/03/31044.2500.0043.0003220.00%
2025/03/27046.1000.0045.9003190.00%
2025/03/25045.3500.0045.8003210.00%
2025/03/19145.5500.0045.3013260.31%
2025/03/18045.8500.0045.8503300.00%
2025/03/0500.00150.2049.60-1324-0.31%
2025/02/26050.60350.8350.80-3272-1.10%
2025/02/2500.00350.7050.60-3268-1.12%
2025/02/2400.00350.4350.10-3276-1.09%
2025/02/13549.3200.0049.4552711.84%
2025/02/12249.9500.0049.9522680.74%
2025/02/11250.2000.0050.4022720.73%
2025/02/1000.001251.8451.60-12268-4.47%
2025/02/07649.95650.8350.5002630.00%
2025/02/0600.001050.0450.90-10258-3.87%
2025/02/041848.9300.0048.60182427.44%
2025/02/03050.302950.6950.70-29238-12.17%
2025/01/22650.5000.0050.3062352.55%
2025/01/2000.00351.2051.20-3232-1.29%
2025/01/16849.7800.0051.0082263.54%
2025/01/153450.2800.0049.303422215.29%
2025/01/14352.07152.3052.1022110.94%
2025/01/09152.30151.6052.3001900.00%
2025/01/0700.00152.9952.10-1176-0.58%
2025/01/0600.00551.4050.80-5159-3.14%
2024/12/1800.00346.8246.50-3130-2.30%
2024/12/1200.00148.8048.40-1126-0.79%
2024/12/0900.00245.6845.95-2104-1.92%
2024/11/04042.80541.8142.10-5126-3.96%
2024/10/2500.00042.2042.4501400.00%
2024/09/04044.9500.0045.0004130.00%
2024/09/0200.00046.4046.5504140.00%
2024/08/2000.00144.0044.05-1427-0.23%
2024/08/050.138.4700.0038.100.14120.03%
2024/07/29044.0000.0043.0004010.01%
2024/07/2300.00145.6545.55-1393-0.25%
2024/07/19547.7400.0046.5053841.30%
2024/07/18145.5000.0048.0013460.29%
2024/07/1600.00544.7944.75-5328-1.52%
2024/07/09045.0000.0044.0503290.00%
2024/07/08047.75247.4547.00-2311-0.64%
2024/07/05149.9500.0049.4013000.33%
2024/07/040.149.3000.0049.550.12950.03%
2024/07/032150.402050.4050.4012840.35%
2024/07/02251.09151.2050.4012620.39%
2024/07/01550.2000.0050.2052142.33%
2024/06/280.246.1000.0046.200.21840.11%
2024/06/270.146.5300.0045.850.11860.03%
2024/06/21146.25146.3546.3001700.00%
2024/06/13344.9000.0044.2531581.89%
2024/06/0600.00344.5044.90-3154-1.94%
2024/06/04044.8000.0044.3001490.01%
2024/05/31342.4500.0042.2531402.13%
2024/05/30042.5000.0042.2001400.00%
2024/05/28142.3500.0042.5511410.71%
2024/05/21043.4500.0043.4001360.00%
2024/04/3000.00042.6042.9001540.00%
2024/04/15345.6000.0044.5531601.87%
2024/04/12346.0000.0045.4031601.87%
2024/04/0900.00545.3245.15-5164-3.04%
〈大江集團法說〉和康生明年營收續拚雙位數成長 淨利率維持25%Anue鉅亨-2023/11/20
和康生三大業務銷售看旺 明、後年將啟動擴產計畫Anue鉅亨-2023/07/25
和康生全年毛利率有望維持67%水準 今年將取得10張認證Anue鉅亨-2023/05/23
和康生 相關文章
 
 
27小時36